MCL coexpression mm9:268: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
|ontology_enrichment_disease= | |ontology_enrichment_disease= | ||
|ontology_enrichment_uberon= | |ontology_enrichment_uberon= | ||
|tfbs_overrepresentation_for_novel_motifs=1.27185,0.311223,0.194973,0.275278,0.224548,0.293623,0.827479,0.365336,0.105359,0.704271,1.18657,0.400509,0.366074,1.38387,0.102784,0,1.36,0.0186281,0.0796869,0.318509,0.040141,0.179381,3.42355,1.02337,0.447985,0.476423,0.29651,1.09758,0.554665,0.490266,0.627721,0.345924,0.979842,0.402733,1.11897,0.0449766,0.933467,1.2852,0.324181,0.124404,0.0865113,0.309235,0.0830791,0.771887,0.162282,1.40835,1.14746,0.69724,0.383882,0.563163,0.711629,0.51729,0.294051,0.462148,0.477006,0.875514,0.926629,0.382447,0.271373,0.870437,0.330215,1.01904,0.119176,1.28272,1.44915,0.277492,0.596353,0.920398,0.326579,0.781435,1.07824,0.871817,0.637505,0.505848,0.13459,0.375237,0.402458,0.591613,0.316915,0.0414786,0.387613,2.99875,1.01533,1.0996,1.05175,0.492312,0.0224947,0.704302,0.215887,1.07627,0.659258,0.412394,0.356069,0.234168,0.0120375,0.273875,0.0922874,0.942051,0.212731,0.246967,0.378383,0.345703,0.44741,0.25656,0.710864,1.57536,3.11716,0.687763,0.37681,3.04728,0.472108,0.448913,0.0418408,1.20451,0.665677,0.0851703,0.549562,0.587754,0.743023,0.368798,0.510527,0.233232,0.158574,0.204297,0.715313,0.319766,0.429603,0.925191,0.594996,0.239081,0.433157,0.56298,0.568676,0.909642,0.685415,0.0991348,0.0659275,0.311081,0.640623,1.43657,1.04548,0.600569,0.16595,0.932997,1.29431,1.57941,0.214675,1.39749,0.0668942,1.86976,0.191837,0.237608,1.1712,0.491826,0.464961,0.533955,0.174709,0.0268793,0.221586,1.30746,0.649247,0.407582,0.32011,0.213736,0.694619,0.45395,0.375337,0.126498,0.411528 | |||
}} | }} |
Revision as of 18:05, 26 November 2012
Phase1 CAGE Peaks
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0006396 | RNA processing | 2.84575510558761e-13 |
GO:0003723 | RNA binding | 9.04964770713806e-10 |
GO:0010467 | gene expression | 6.58462118452629e-09 |
GO:0006139 | nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 2.4425123101148e-08 |
GO:0022613 | ribonucleoprotein complex biogenesis and assembly | 9.6640159363622e-08 |
GO:0006397 | mRNA processing | 2.87880327723895e-07 |
GO:0016071 | mRNA metabolic process | 5.36733190548972e-07 |
GO:0008380 | RNA splicing | 1.71344843459706e-06 |
GO:0000178 | exosome (RNase complex) | 5.70283950895519e-06 |
GO:0016070 | RNA metabolic process | 5.87107282851618e-06 |
GO:0016072 | rRNA metabolic process | 1.05109240237543e-05 |
GO:0006364 | rRNA processing | 1.05109240237543e-05 |
GO:0044238 | primary metabolic process | 1.11171430359242e-05 |
GO:0030529 | ribonucleoprotein complex | 1.11171430359242e-05 |
GO:0044237 | cellular metabolic process | 1.11171430359242e-05 |
GO:0005681 | spliceosome | 1.11171430359242e-05 |
GO:0043170 | macromolecule metabolic process | 3.74004777176496e-05 |
GO:0005634 | nucleus | 5.47837026515738e-05 |
GO:0032991 | macromolecular complex | 7.35848035621704e-05 |
GO:0042254 | ribosome biogenesis and assembly | 0.000186471419281264 |
GO:0016742 | hydroxymethyl-, formyl- and related transferase activity | 0.000186471419281264 |
GO:0003676 | nucleic acid binding | 0.000222696387637151 |
GO:0004527 | exonuclease activity | 0.000256765118792631 |
GO:0004372 | glycine hydroxymethyltransferase activity | 0.000342140868387165 |
GO:0043283 | biopolymer metabolic process | 0.000401000647743775 |
GO:0022618 | protein-RNA complex assembly | 0.000859282418816777 |
GO:0044428 | nuclear part | 0.00105556349000239 |
GO:0016043 | cellular component organization and biogenesis | 0.00160364658245473 |
GO:0000245 | spliceosome assembly | 0.0028027044199249 |
GO:0044424 | intracellular part | 0.00329603599130794 |
GO:0043229 | intracellular organelle | 0.00385128503489917 |
GO:0043226 | organelle | 0.00385128503489917 |
GO:0004518 | nuclease activity | 0.00451318536050928 |
GO:0005622 | intracellular | 0.00523634913168027 |
GO:0008168 | methyltransferase activity | 0.00682189229167808 |
GO:0016741 | transferase activity, transferring one-carbon groups | 0.00682189229167808 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 0.00682189229167808 |
GO:0000398 | nuclear mRNA splicing, via spliceosome | 0.00682189229167808 |
GO:0000375 | RNA splicing, via transesterification reactions | 0.00682189229167808 |
GO:0009113 | purine base biosynthetic process | 0.00682189229167808 |
GO:0046607 | positive regulation of centrosome cycle | 0.00682189229167808 |
GO:0004641 | phosphoribosylformylglycinamidine cyclo-ligase activity | 0.00682189229167808 |
GO:0046602 | regulation of mitotic centrosome separation | 0.00682189229167808 |
GO:0046605 | regulation of centrosome cycle | 0.00682189229167808 |
GO:0045437 | uridine nucleosidase activity | 0.00682189229167808 |
GO:0016074 | snoRNA metabolic process | 0.00682189229167808 |
GO:0004644 | phosphoribosylglycinamide formyltransferase activity | 0.00682189229167808 |
GO:0003937 | IMP cyclohydrolase activity | 0.00682189229167808 |
GO:0004643 | phosphoribosylaminoimidazolecarboxamide formyltransferase activity | 0.00682189229167808 |
GO:0046604 | positive regulation of mitotic centrosome separation | 0.00682189229167808 |
GO:0051028 | mRNA transport | 0.00800341206382138 |
GO:0006996 | organelle organization and biogenesis | 0.00800341206382138 |
GO:0043231 | intracellular membrane-bound organelle | 0.00800341206382138 |
GO:0043227 | membrane-bound organelle | 0.00800341206382138 |
GO:0051236 | establishment of RNA localization | 0.00800341206382138 |
GO:0050657 | nucleic acid transport | 0.00800341206382138 |
GO:0050658 | RNA transport | 0.00800341206382138 |
GO:0006403 | RNA localization | 0.00818292632174482 |
GO:0015931 | nucleobase, nucleoside, nucleotide and nucleic acid transport | 0.00934457117399923 |
GO:0004844 | uracil DNA N-glycosylase activity | 0.0100264232315109 |
GO:0046040 | IMP metabolic process | 0.0100264232315109 |
GO:0006189 | 'de novo' IMP biosynthetic process | 0.0100264232315109 |
GO:0006188 | IMP biosynthetic process | 0.0100264232315109 |
GO:0030515 | snoRNA binding | 0.0100264232315109 |
GO:0051299 | centrosome separation | 0.0100264232315109 |
GO:0007100 | mitotic centrosome separation | 0.0100264232315109 |
GO:0004637 | phosphoribosylamine-glycine ligase activity | 0.0100264232315109 |
GO:0006164 | purine nucleotide biosynthetic process | 0.0112988392980572 |
GO:0006310 | DNA recombination | 0.0140014647333496 |
GO:0006163 | purine nucleotide metabolic process | 0.0140014647333496 |
GO:0016882 | cyclo-ligase activity | 0.0140014647333496 |
GO:0006379 | mRNA cleavage | 0.0140014647333496 |
GO:0044446 | intracellular organelle part | 0.0144112696167113 |
GO:0044422 | organelle part | 0.0145353275771984 |
GO:0019238 | cyclohydrolase activity | 0.017921387915388 |
GO:0046112 | nucleobase biosynthetic process | 0.0220980893118266 |
GO:0065003 | macromolecular complex assembly | 0.0223042678357786 |
GO:0016779 | nucleotidyltransferase activity | 0.0256271454173277 |
GO:0005730 | nucleolus | 0.0257701017514945 |
GO:0016787 | hydrolase activity | 0.0272455153924382 |
GO:0015030 | Cajal body | 0.0279933635356416 |
GO:0007098 | centrosome cycle | 0.0279933635356416 |
GO:0006144 | purine base metabolic process | 0.0279933635356416 |
GO:0009165 | nucleotide biosynthetic process | 0.0302783473221256 |
GO:0051297 | centrosome organization and biogenesis | 0.0302783473221256 |
GO:0002566 | somatic diversification of immune receptors via somatic mutation | 0.0302783473221256 |
GO:0016446 | somatic hypermutation of immunoglobulin genes | 0.0302783473221256 |
GO:0022607 | cellular component assembly | 0.0302783473221256 |
GO:0031023 | microtubule organizing center organization and biogenesis | 0.0328576281770539 |
GO:0000175 | 3'-5'-exoribonuclease activity | 0.0328576281770539 |
GO:0019104 | DNA N-glycosylase activity | 0.0328576281770539 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 0.0357193414185093 |
GO:0009127 | purine nucleoside monophosphate biosynthetic process | 0.0357193414185093 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 0.0384590397326422 |
GO:0009126 | purine nucleoside monophosphate metabolic process | 0.0384590397326422 |
GO:0006412 | translation | 0.039978205275709 |
GO:0031202 | RNA splicing factor activity, transesterification mechanism | 0.0402705752914268 |
GO:0004532 | exoribonuclease activity | 0.0423436693409843 |
GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters | 0.0423436693409843 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 0.0423436693409843 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 0.0446020580687409 |
GO:0007051 | spindle organization and biogenesis | 0.0446020580687409 |
GO:0044249 | cellular biosynthetic process | 0.0446020580687409 |
GO:0005732 | small nucleolar ribonucleoprotein complex | 0.0457243882494226 |
GO:0008408 | 3'-5' exonuclease activity | 0.0457243882494226 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 0.0457243882494226 |
GO:0009112 | nucleobase metabolic process | 0.0457243882494226 |
GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds | 0.0478819462112155 |
GO:0009123 | nucleoside monophosphate metabolic process | 0.0478819462112155 |
GO:0009117 | nucleotide metabolic process | 0.0492322474392219 |
GO:0006284 | base-excision repair | 0.049961101762453 |
Relative expression of the co-expression cluster over median <br>Analyst:
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br><br><br>
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |